October 05, 2016
The US Food and Drug Administration (FDA) reported the recall of one lot of lansoprazole delayed-release capsules, USP, 30 mg (NDC 63739-0555-10).
What prompted the Class III recall? The inner packaging incorrectly indicated that the medication was omeprazole.
The impacted lot is #0111295, with an expiration of September 2017.
The products were manufactured by Dr. Reddy’s Laboratories for Mckesson Packaging Services.
Mckesson Packaging Services just launched a recall of alprazolam because the blister cards did not contain any product information.
In April, Dr. Reddy’s Laboratories launched a recall of zoledronic acid injection due to defective seals.